Cibus, a gene editing technology company, says it has completed what it believes is the first regeneration of wheat from a single cell, offering new possibilities for innovation in the global staple crop.
Cibus (NASDAQ:CBUS – Get Free Report) and ICL Group (NYSE:ICL – Get Free Report) are both consumer staples companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk. Insider & Institutional Ownership 21.7% of Cibus shares […]
Cibus (NASDAQ:CBUS – Get Free Report) is one of 17 publicly-traded companies in the “Agricultural chemicals” industry, but how does it weigh in compared to its competitors? We will compare Cibus to related companies based on the strength of its profitability, risk, dividends, valuation, earnings, analyst recommendations and institutional ownership. Earnings and Valuation This table […]
Cibus (NASDAQ:CBUS – Get Free Report) is one of 20 publicly-traded companies in the “Agricultural chemicals” industry, but how does it contrast to its peers? We will compare Cibus to related businesses based on the strength of its profitability, analyst recommendations, earnings, valuation, institutional ownership, risk and dividends. Valuation & Earnings This table compares Cibus […]
Cibus (NASDAQ:CBUS – Get Free Report) and Nutrien (NYSE:NTR – Get Free Report) are both consumer staples companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, institutional ownership and valuation. Profitability This table compares Cibus and Nutrien’s net margins, […]